SALEKI-GERHARDT AZITA 4
4 · AbbVie Inc. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
AbbVie EVP Azita Saleki-Gerhardt Sells 16,309 Shares
What Happened
Azita Saleki-Gerhardt, Executive Vice President and Chief Operations Officer of AbbVie (ABBV), had 16,309 shares disposed/withheld to satisfy tax obligations related to an option exercise. The shares were valued at $232.08 each, for a total of $3,784,993. This was a withholding/disposition to cover taxes (Form 4 transaction code F), not an open-market sale.
Key Details
- Transaction date: 2026-02-27; Filing date: 2026-03-03 (Form 4 accession 0001563545-26-000004) — filing appears timely.
- Price per share: $232.08; Shares withheld/disposed: 16,309; Total value: $3,784,993.
- Transaction code: F — payment of exercise price or tax liability by delivering/withholding securities.
- Shares owned after the transaction: not specified in the provided excerpt.
- Footnotes: F1 notes the balance used was from the AbbVie Savings program as of Feb 20, 2026, including shares from dividend reinvestment; F2 disclaims beneficial ownership of securities held by her spouse.
Context
When insiders have shares withheld to cover taxes after exercising options, it is typically an administrative/ tax-related transaction rather than a discretionary open-market sale. Such withholdings reduce holdings but do not necessarily indicate a change in the insider’s view of the company.
Insider Transaction Report
- Tax Payment
Common Stock, $0.01 par value
2026-02-27$232.08/sh−16,309$3,784,993→ 197,794 total
- 2,706(indirect: By Trust)
Common Stock, $0.01 par value
[F1] - 3,873(indirect: By Spouse)
Common Stock, $0.01 par value
[F2]
Footnotes (2)
- [F1]Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.
- [F2]The reporting person disclaims beneficial ownership of all securities held by her spouse.